This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Off the Cuff January 28, 2019
Off the Cuff: CVH Clinical and Community Connections for State & Local Public Health Departments
Information from state and national partners
Facilitated by the Cardiovascular Health Network of NACDD
Issue 131, January 28, 2019
Contact us at

From the CVH Advisory Council 

Brittany Brown, (Utah) Chair

Dear CVH Network Members,
It is a pleasure to introduce myself as Chair for the CVH Advisory Council (formerly the CVH Network Leadership Team). The Advisory Council helps to inform NACDD and CDC Division for Heart Disease and Stroke Prevention learning and technical assistance states need related to Category B of 1815 and 1817. In my role in Utah, I am the Epidemiology and Evaluation Manager for Utah’s Healthy Living Through Environment, Policy, and Improved Clinical Care Program working on the 1815, 1817 and State Physical Activity and Nutrition grants. Some of my goals with the Advisory Council are to facilitate better connections among epidemiology and evaluation and program implementation, and to ensure that states are being heard and training and technical assistance needs related to Category B are prioritized and communicated to NACDD and CDC.

Thanks to all who participated in the election of our Advisory Council representatives in December. Please join me in extending a warm welcome and congratulations to the 2019 CVH Advisory Council representatives: Alexis Barnett-Sherrill (HI), Kristina Dawkins (MI), Desiree Jonas (FL), Victor Sutton (MS), Janna Pastir (ND), Tara Trujillo (CO), Cheryl Farmer (WA), Rachael Austin (NY), Crystelle Fogle (MT), and Paul Meddaugh (VT). Sara Eve Sarliker (WA) and Robin Roberts (MI) are continuing liaisons for the Diabetes and WISEWOMAN Councils, respectively. Belle Federman, Lara Kaye, and Shelby Vadjunec represent the Epidemiology and Evaluation Collaborative (EEC). More information on our representatives, including their contact information and role on the Advisory Council, is available on our webpage
Please feel free to reach out to any Advisory Council representative at any time to share your ideas, recommendations, and needs related to Category B. Advisory Council meetings are held the fourth Wednesday of each month. You can reach me directly at I am excited to work with you on our new cardiovascular disease prevention and management work, and look forward to hearing from you.

News and Resources from CDC, NACDD and National Partners

From NACDD and CDC
Request for Applications (RFA): GIS Translation/Dissemination Capacity Building for State Health Departments
NACDD, in partnership with the CDC Division for Heart Disease and Stroke Prevention and the Children’s Environmental Health Initiative at Rice University, is requesting applications for the 2019 Geographic Information Systems (GIS) Translation/Dissemination Capacity Building for State Health Departments: Advancing the Translation and Dissemination of Maps for Heart Disease and Stroke Prevention.  All state health departments are eligible to apply. The instructions for completing the application can be found here.
A Question and Answer session regarding the RFA will be held on Thursday, Jan. 31, 2 – 3:00 p.m. ET. Register here for the session. The call will be recorded and posted on the NACDD GIS webpage within 2 days following the webinar, along with Frequently Asked Questions. Applications are due Feb. 22. Notice of awards will be made by March 8. For additional information, contact Hannah Herold,


From CDC Division for Heart Disease and Stroke Prevention
DP18-1815 Category B Updated Evaluation and Performance Measure Documents

The webinar on January 17th provided an overview of the Category B national evaluation and highlighted updates to performance measure definitions based on recipient feedback. Click the hyperlinks to view the slide deck and written Q&A from the call. To listen to the recording of the entire presentation and discussion, please access:

If you have any questions, please contact Marla Vaughan (
DP18-1815 Category B Performance Measure Guidance and Definitions Version 2
This document has been updated since version 1 was distributed in October to incorporate recipient written feedback and input from discussions with recipient Performance Measure Action Teams. The document provides an overview of the 1815 evaluation approach; outlines performance measure requirements; describes how performance measures were operationalized; highlights helpful hints for performance measure baselines, targets, and reporting; offers a glossary of key terms; and provides final revised performance measure definitions.
DP-18-1815 Category B Evaluation and Performance Measurement Plan Guidance Version 2
This document has been updated since version 1 was distributed in October with clarifications and minor edits based on questions received from recipients. The overall guidance and requirements remain the same as version 1. Please contact your CDC Category B Evaluator with any questions.


Example table for 1815 Category B Evaluation and Performance Measurement Plan (EPMP) 

For an example table that you may find helpful as a starting point as you prepare your 1815 category B EPMP, click here

From CDC Division for Heart Disease and Stroke Prevention
Review and Feedback wanted for DP18-1817 Category B Performance Measure Guidance and Draft Definitions
Before CDC finalizes the Category B DP18-1817 Performance Measure Guidance and Definitions they would like to give all of the 1817 recipients an opportunity to comment on the 1817 draft performance measure definitions. To provide feedback, follow the steps below:
1. Take some time to review the performance measure definitions link. (Some
     performance measures have questions and comments included for your
2. Ask yourself the following questions:
    a. What have we considered as we thought about reporting on the performance
         measures outlined in the NOFO?
     b. What have we learned about available data sources?
     c. Are there any tips we think other recipients could benefit from to ensure we
         all can report accurately for each strategy?
 3. Provide your feedback in an email specifying your responses by the measure(s)
     where you think it would be most helpful. For example, you might add:
     a. Performance Measure B.1: There are other data sources that could be used to
         address this measure. We suggest adding (blank) and (blank) as data sources.
     b. Performance Measure B.6: In our experience there are a few things to be sure of
         when reporting this kind of measure. Consider adding (blank) to the Helpful Hints
Send the email with your feedback to by COB on Jan. 31.
There will be an 1817 Category B Evaluation and Performance Measure Plan and Performance Measure Guidance and Definitions Webinar on Feb.19, at 3:00 p.m. ET. Please save the date and plan to attend. Thank you in advance for your insightful feedback and suggestions. 

This email was sent to *|EMAIL|*
why did I get this?    unsubscribe from this list    update subscription preferences


National Association of Chronic Disease Directors
325 Swanton Way
Decatur, GA 30030
(770) 458-7400
Hours of Operation: Mon. - Fri., 8 a.m. - 4:30 p.m.